These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21965755)

  • 1. Tumor endothelial marker 8 expression in triple-negative breast cancer.
    Gutwein LG; Al-Quran SZ; Fernando S; Fletcher BS; Copeland EM; Grobmyer SR
    Anticancer Res; 2011 Oct; 31(10):3417-22. PubMed ID: 21965755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progranulin expression in breast cancer with different intrinsic subtypes.
    Li LQ; Min LS; Jiang Q; Ping JL; Li J; Dai LC
    Pathol Res Pract; 2012 Apr; 208(4):210-6. PubMed ID: 22397762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor endothelial marker 8 enhances tumor immunity in conjunction with immunization against differentiation Ag.
    Felicetti P; Mennecozzi M; Barucca A; Montgomery S; Orlandi F; Manova K; Houghton AN; Gregor PD; Concetti A; Venanzi FM
    Cytotherapy; 2007; 9(1):23-34. PubMed ID: 18236207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor endothelial marker 8 overexpression in breast cancer cells enhances tumor growth and metastasis.
    Opoku-Darko M; Yuen C; Gratton K; Sampson E; Bathe OF
    Cancer Invest; 2011 Dec; 29(10):676-82. PubMed ID: 22085271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibin/activin subunits (inhibin-alpha, -betaA and -betaB) are differentially expressed in human breast cancer and their metastasis.
    Mylonas I; Jeschke U; Shabani N; Kuhn C; Friese K; Gerber B
    Oncol Rep; 2005 Jan; 13(1):81-8. PubMed ID: 15583806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEM8/ANTXR1-Specific CAR T Cells as a Targeted Therapy for Triple-Negative Breast Cancer.
    Byrd TT; Fousek K; Pignata A; Szot C; Samaha H; Seaman S; Dobrolecki L; Salsman VS; Oo HZ; Bielamowicz K; Landi D; Rainusso N; Hicks J; Powell S; Baker ML; Wels WS; Koch J; Sorensen PH; Deneen B; Ellis MJ; Lewis MT; Hegde M; Fletcher BS; St Croix B; Ahmed N
    Cancer Res; 2018 Jan; 78(2):489-500. PubMed ID: 29183891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen triple helix repeat containing 1 protein, periostin and versican in primary and metastatic breast cancer: an immunohistochemical study.
    Kharaishvili G; Cizkova M; Bouchalova K; Mgebrishvili G; Kolar Z; Bouchal J
    J Clin Pathol; 2011 Nov; 64(11):977-82. PubMed ID: 21742751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The morphology of triple negative breast cancer].
    Karseladze DA; Poddubnaia IV; Karseladze AI
    Arkh Patol; 2010; 72(2):8-12. PubMed ID: 20698308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.
    Duan HF; Hu XW; Chen JL; Gao LH; Xi YY; Lu Y; Li JF; Zhao SR; Xu JJ; Chen HP; Chen W; Wu CT
    J Natl Cancer Inst; 2007 Oct; 99(20):1551-5. PubMed ID: 17925540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53, Ki-67, E-cadherin, N-cadherin and TOP2A in triple-negative breast cancer.
    Nakagawa M; Bando Y; Nagao T; Morimoto M; Takai C; Ohnishi T; Honda J; Moriya T; Izumi K; Takahashi M; Sasa M; Tangoku A
    Anticancer Res; 2011 Jun; 31(6):2389-93. PubMed ID: 21737670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Triple-negative breast carcinoma--rewiev of current literature].
    Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
    Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer.
    Sjöström-Mattson J; Von Boguslawski K; Bengtsson NO; Mjaaland I; Salmenkivi K; Blomqvist C
    Acta Oncol; 2009; 48(8):1137-43. PubMed ID: 19863221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF-D in association with VEGFR-3 promotes nodal metastasis in human invasive lobular breast cancer.
    van Iterson V; Leidenius M; von Smitten K; Bono P; Heikkilä P
    Am J Clin Pathol; 2007 Nov; 128(5):759-66. PubMed ID: 17951197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.
    Bandić D; Juretić A; Sarcević B; Separović V; Kujundzić-Tiljak M; Hudolin T; Spagnoli GC; Cović D; Samija M
    Croat Med J; 2006 Feb; 47(1):32-41. PubMed ID: 16489695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mRNA markers of breast cancer nodal metastases: comparison between mammaglobin and carcinoembryonic antigen in 248 patients.
    Marchetti A; Buttitta F; Bertacca G; Zavaglia K; Bevilacqua G; Angelucci D; Viacava P; Naccarato A; Bonadio A; Barassi F; Felicioni L; Salvatore S; Mucilli F
    J Pathol; 2001 Sep; 195(2):186-90. PubMed ID: 11592097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G-protein coupled receptor-associated sorting protein 1 (GASP-1), a potential biomarker in breast cancer.
    Tuszynski GP; Rothman VL; Zheng X; Gutu M; Zhang X; Chang F
    Exp Mol Pathol; 2011 Oct; 91(2):608-13. PubMed ID: 21791203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic initiation factor 4E overexpression in triple-negative breast cancer predicts a worse outcome.
    Flowers A; Chu QD; Panu L; Meschonat C; Caldito G; Lowery-Nordberg M; Li BD
    Surgery; 2009 Aug; 146(2):220-6. PubMed ID: 19628077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential TAG-72 epitope expression in breast cancer and lymph node metastases: a marker of a more aggressive phenotype.
    Galietta A; Pizzi C; Pettinato G; Limite G; Sgambato A; Lamberti M; Muraro R; Formisano C; Pensabene M; Bianco AR; Mariani-Costantini R; Contegiacomo A
    Oncol Rep; 2002; 9(1):135-40. PubMed ID: 11748471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.